The global infection prevention product and services market is estimated to grow at a CAGR of 5.66% to reach a market size of US$225.847 billion in 2030 from US$171.502 billion in 2025.
The growing number of acute and chronic diseases is propelling the market growth.
Chronic diseases include cardiovascular diseases, the prevalence of cancer, asthma, and COPD, among others. Concerns regarding hospital-associated infections, surgical-site infections, and medical waste disposal are allowing the market to proliferate in the forecast period.
The increasing awareness of infection control across healthcare settings, growing healthcare-associated infections (HAIs), and the rising elderly population with weakened immune systems are driving the global infection prevention products and services market. Governments and regulatory bodies worldwide are enforcing strict infection control protocols, increasing demand for sterilization equipment, disinfectants, and personal protective equipment (PPE). The increasing number of chronic diseases and invasive procedures drive the market as hospitals and clinics embrace advanced infection prevention solutions.
Healthcare services categorized as primary care, secondary care, tertiary care, and quaternary care are also driving the market during the forecast period. Primary care involves healthcare professionals who play a role in the local community. This provides care to patients of all ages and socioeconomic and geographic regions. Various chronic illnesses can be treated under primary care, including hypertension, diabetes, depression, and anxiety. The professionals involved in primary care would usually be general practitioners or family doctors. Other professionals include nurses or physiotherapists. The key characteristic of primary care is continuity, which consists of routine check-ups and preventive care. Depending on the patient's condition, they may be advised for secondary or tertiary care.
Secondary care includes the treatment of serious illnesses that require immediate action for a shorter period. One can find this kind of facility in the hospital's emergency department, which requires skilled professionals and attendants. Tertiary care is for specialized healthcare services. The personnel are referred via primary and secondary care and require advanced medical investigation and treatment facilities. Examples include cardiac and other complex surgeries. Quaternary care is an extension of tertiary care and uses advanced and highly specialized treatments and care. These are not widely accessible but still provide a favorable growth opportunity for the market to proliferate in the forecast period.
The growing geriatric population has given rise to an increase in healthcare costs required for the treatment of non-communicable diseases and chronic diseases related to old age. Population aging and growth at advanced stages, above 65 years of age, is raising concerns such as pressure on health systems, which must adapt to meet the growing demands for care, services, and technologies for preventing and treating age-associated non-communicable and chronic diseases. For instance, according to the World Economic Forum, more than 1 in 10 people in Japan are now older than 60. Almost two-thirds of the population, or an estimated 36.23 million people, were aged over 65 years in 2023.
Similarly, according to the Administration for Community Living (ACL) in the United States, in 2022, 57.8 million people aged 65 years or older in the country. They constitute 17.3% of the population, more than 1 in every 6 Americans. Since 2012, the number of older Americans has grown by 34% (14.7 million), compared with an increase of 2% in the population under 65. Hence, the increasing older population in various countries is expected to positively influence the market for global infection prevention products and services in the projected period.
Additionally, as non-communicable diseases and the potential economic & societal costs of these diseases rise with age, they can also affect economic growth. Hence, the growing geriatric population will greatly impact the global infection prevention product and services market expansion over the next five years. With the increasing elderly population, there is a significant increase in home healthcare services. Thus, this is further surging the market growth in the upcoming years.
The global infection prevention products and services market by end-user is segmented into hospitals, clinics, ambulatory surgery centers (ASCs), diagnostic centers, and life sciences & biomedical research organizations. Hospitals have a major market share due to the high volume of patients, complex procedures, and stringent infection control protocols required to prevent healthcare-associated infections (HAIs).
Clinics also contribute significantly, especially in outpatient care, where proper infection prevention is crucial to protecting patients and staff. Ambulatory surgery centers (ASCs) are experiencing increased demand for sterilization and disinfection products as outpatient surgeries increase.
Diagnostic centers use infection prevention products to ensure that testing is done in a sterile environment and to protect the patient. Life sciences and biomedical research organizations require stringent measures for contamination control to protect research integrity and comply with regulatory standards, increasing the demand for sophisticated infection prevention solutions. The diverse end-user landscape indicates that infection control is critical for healthcare and research settings across all spectrums.
Based on geography, the global men's grooming products market has been segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. The North American region is projected to hold a notable share throughout the forecast period because of the high number of advanced healthcare facilities. Efforts are made to maintain these facilities, emphasizing infection prevention and control in this region. Additionally, the presence of prominent market players in the region is further increasing the market demand in the forecast period and the coming years.
On the other hand, the Asia Pacific region is the fastest-growing region due to the high prevalence of chronic diseases that demand treatment. With the highest number of geriatric populations in Japan, the APAC region holds strong growth prospects for the market to grow significantly in the forecast period. Furthermore, the booming medical tourism industry and the growing number of surgeries and minimally invasive and robotic surgeries are further propelling the market in the forecast period.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Infection Prevention Product and Services Market Size in 2025 | US$171.502 billion |
| Infection Prevention Product and Services Market Size in 2030 | US$225.847 billion |
| Growth Rate | CAGR of 5.66% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Billion |
| Segmentation |
|
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in the Infection Prevention Product and Services Market | |
| Customization Scope | Free report customization with purchase |